Established in 1997, this fully remote company is a nationally
recognized leader in behavior change science, with a proven
track record of delivering innovative solutions to clients across
the United States. Offering a comprehensive suite of services,
including software as a service (SaaS) digital well-being
solution, intellectual property licensing, consulting for
organizations seeking to apply behavior change science,
research and development projects funded by both public and
private sectors, and professional training and speaking
engagements. The company’s client base includes health
systems, health plans, large employers, government agencies
(such as NIH and CDC), wellness platform providers,
universities, and major corporations like Adidas and the
Lupus Foundation of America. With a staff of 12 experienced
professionals, including PhD-level behavior scientists,
master’s-level project managers, technology specialists, and
long-tenured support staff—the business is well-positioned to
deliver high-quality, science-driven solutions. Most team
members have been with the company for over a decade,
reflecting a stable and committed workforce. The sellers
remain actively involved, from strategic direction and
administration to project oversight. They are seeking a sale to
ensure the long-term sustainability and continued success of
the company and are open to staying on for 2-3 years to
facilitate a seamless transition. Additionally, the sellers have
offered to carry 15% of the purchase price as a show of faith
in the continued success of the business post close.

Priced at $1,000,000, this is a great opportunity to acquire a
highly reputable, science-based firm with a strong foundation,
and loyal clients. Growth opportunities are substantial, with
potential to expand through the integration of generative AI,
participation in the rapidly growing fields of lifestyle medicine
and value-based care, addressing the needs of an aging
population, and developing new offerings in mental health,
organizational well-being, and public health initiatives.